Ocular Therapeutix, Inc
OCUL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001393434
In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Ocular Therapeutix, Inc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 130
- +7 vs. Q2 2022
- Shares held
- 42.8M
- −1.53M (−3.5%) vs. Q2 2022
- Total value
- $177.6M
- −$594.3K (−0.3%) vs. Q2 2022
- New holders
- 21
- 44 more added
- Sold out
- 14
- 36 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OCUL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 262 | $2.03B |
| Q1 2026 | 271 | $1.77B |
| Q4 2025 | 249 | $2.33B |
| Q3 2025 | 216 | $2.20B |
| Q2 2025 | 187 | $1.45B |
| Q1 2025 | 197 | $1.01B |
| Q4 2024 | 180 | $1.14B |
| Q3 2024 | 168 | $1.22B |
| Q2 2024 | 151 | $939.8M |
| Q1 2024 | 147 | $1.12B |
| Q4 2023 | 119 | $328.8M |
| Q3 2023 | 114 | $127.0M |
| Q2 2023 | 135 | $224.2M |
| Q1 2023 | 127 | $213.8M |
| Q4 2022 | 116 | $111.3M |
| Q3 2022 | 130 | $177.6M |
| Q2 2022 | 123 | $178.2M |
| Q1 2022 | 132 | $215.4M |
| Q4 2021 | 140 | $289.1M |
| Q3 2021 | 141 | $445.7M |
| Q2 2021 | 149 | $685.8M |
| Q1 2021 | 154 | $774.9M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Ocular Therapeutix, Inc; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Charles Schwab Investment Management Inc | 200,787 | $834.0K | 0.00% | +418+0.2% | Added |
| UBS Oconnor LLC | 223,066 | $926.0K | 0.01% | −289,820−56.5% | Reduced |
| Wellington Management Group LLP | 238,632 | $991.0K | 0.00% | −10,627−4.3% | Reduced |
| Levin Capital Strategies, L.P. | 255,844 | $1.06M | 0.15% | +123,190+92.9% | Added |
| Nuveen Asset Management, LLC | 257,262 | $1.07M | 0.00% | −90,835−26.1% | Reduced |
| Ikarian Capital, LLC | 265,000 | $1.10M | 0.55% | +265,000 | New |
| Bank of New York Mellon Corp | 270,610 | $1.12M | 0.00% | +21,592+8.7% | Added |
| Los Angeles Capital Management LLC | 275,984 | $1.15M | 0.01% | 00.0% | Unchanged |
| Ieq Capital, LLC | 283,933 | $1.18M | 0.03% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 296,705 | $1.23M | 0.00% | +263,385+790.5% | Added |
| Goldman Sachs Group Inc | 332,747 | $1.38M | 0.00% | −135,501−28.9% | Reduced |
| Banco Santander, S.A. | 352,811 | $1.46M | 0.02% | −203,073−36.5% | Reduced |
| Two Sigma Advisers, LP | 356,200 | $1.48M | 0.00% | −32,900−8.5% | Reduced |
| Altium Capital Management LP | 517,133 | $2.15M | 0.81% | −177,867−25.6% | Reduced |
| Marshall Wace, LLP | 531,636 | $2.21M | 0.01% | +531,636 | New |
| Cetera Investment Advisers | 604,550 | $2.51M | 0.05% | +5,400+0.9% | Added |
| Northern Trust Corp | 652,877 | $2.71M | 0.00% | −14,704−2.2% | Reduced |
| D. E. Shaw & Co., Inc. | 792,289 | $3.29M | 0.01% | +43,824+5.9% | Added |
| Federated Hermes, Inc. | 801,736 | $3.33M | 0.01% | −390,336−32.7% | Reduced |
| Endurant Capital Management LP | 1,064,295 | $4.42M | 1.44% | +304,067+40.0% | Added |
| Emerald Mutual Fund Advisers Trust | 1,082,103 | $4.49M | 0.28% | +37,371+3.6% | Added |
| Geode Capital Management, LLC | 1,370,753 | $5.69M | 0.00% | +19,328+1.4% | Added |
| Citadel Advisors LLC | 1,392,425 | $5.78M | 0.01% | −331,568−19.2% | Reduced |
| State Street Corp | 1,399,346 | $5.81M | 0.00% | −12,481−0.9% | Reduced |
| Emerald Advisers, LLC | 1,506,456 | $6.25M | 0.32% | +40,754+2.8% | Added |
| Deltec Asset Management LLC | 2,323,673 | $9.64M | 2.37% | +254,360+12.3% | Added |
| Vanguard Group Inc | 3,951,806 | $16.4M | 0.00% | +53,255+1.4% | Added |
| BlackRock Inc. | 4,803,961 | $19.9M | 0.00% | +8,358+0.2% | Added |
| Summer Road LLC | 6,094,761 | $25.3M | 100.00% | +150,000+2.5% | Added |
| Opaleye Management Inc. | 6,465,000 | $26.8M | 11.08% | +490,200+8.2% | Added |
| MSD Partners, L.P. | 0 | $0 | 0.00% | −1,016,302−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −511,195−100.0% | Sold out |
| Kamunting Street Capital Management, L.P. | 0 | $0 | 0.00% | −275,506−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −127,978−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −45,987−100.0% | Sold out |
| Versor Investments LP | 0 | $0 | 0.00% | −33,400−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −29,050−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −18,459−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −16,200−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −13,171−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −10,137−100.0% | Sold out |
| Ahrens Investment Partners LLC | 0 | $0 | 0.00% | −8,000−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −4,162−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −2,370−100.0% | Sold out |